Latozinemab (Anti-Sortilin / SORT1)
Latozinemab (anti-Sortilin / SORT1) is a recombinant humanized anti-Sortilin monoclonal antibody. Latozinemab has the potential for progranulin gene (GRN) mutations causative of frontotemporal dementia (FTD) (FTD-GRN) research. MW: 146.28 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2920 |
| Sku # | A2920-1mg*25 |
| Pricing | 1mg*25, $5070.00 |